These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28466781)

  • 1. Diagnostic and prognostic value of scavenger receptor class B type 1 in clear cell renal cell carcinoma.
    Xu G; Lou N; Xu Y; Shi H; Ruan H; Xiao W; Liu L; Xiao H; Qiu B; Bao L; Yuan C; Chen K; Yang H; Zhang X
    Tumour Biol; 2017 May; 39(5):1010428317699110. PubMed ID: 28466781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma.
    Xu GH; Lou N; Shi HC; Xu YC; Ruan HL; Xiao W; Liu L; Li X; Xiao HB; Qiu B; Bao L; Yuan CF; Zhou YL; Hu WJ; Chen K; Yang HM; Zhang XP
    BMC Cancer; 2018 Jan; 18(1):88. PubMed ID: 29357836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma.
    Shin SJ; Jeon YK; Cho YM; Lee JL; Chung DH; Park JY; Go H
    Oncologist; 2015 Nov; 20(11):1253-60. PubMed ID: 26424759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma.
    Ha YS; Lee GT; Modi P; Kwon YS; Ahn H; Kim WJ; Kim IY
    J Urol; 2015 Nov; 194(5):1441-8. PubMed ID: 25796113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High scavenger receptor class B type I expression is related to tumor aggressiveness and poor prognosis in breast cancer.
    Yuan B; Wu C; Wang X; Wang D; Liu H; Guo L; Li XA; Han J; Feng H
    Tumour Biol; 2016 Mar; 37(3):3581-8. PubMed ID: 26456958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.
    Wu K; Xu L; Zhang L; Lin Z; Hou J
    Jpn J Clin Oncol; 2011 Mar; 41(3):411-6. PubMed ID: 21062756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
    Fu H; Liu Y; Xu L; Liu W; Fu Q; Liu H; Zhang W; Xu J
    Tumour Biol; 2015 Aug; 36(8):5791-9. PubMed ID: 25716202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLIN3 is up-regulated and correlates with poor prognosis in clear cell renal cell carcinoma.
    Wang K; Ruan H; Song Z; Cao Q; Bao L; Liu D; Xu T; Xiao H; Wang C; Cheng G; Tong J; Meng X; Yang H; Chen K; Zhang X
    Urol Oncol; 2018 Jul; 36(7):343.e9-343.e19. PubMed ID: 29773494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
    Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
    Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
    Zhao X; Zhao Z; Xu W; Hou J; Du X
    Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma.
    Liu Y; Yang L; An H; Chang Y; Zhang W; Zhu Y; Xu L; Xu J
    Sci Rep; 2015 Nov; 5():16954. PubMed ID: 26599282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of mucin 18 is associated with unfavorable postoperative prognosis in patients with clear cell renal cell carcinoma.
    Bai Q; Liu L; Long Q; Xia Y; Wang J; Xu J; Guo J
    Int J Clin Exp Pathol; 2015; 8(9):11005-14. PubMed ID: 26617818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma.
    Stein J; Tenbrock J; Kristiansen G; Müller SC; Ellinger J
    Int J Urol; 2019 Sep; 26(9):910-916. PubMed ID: 31280487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma.
    Wang Y; Gao W; Xu J; Zhu Y; Liu L
    Tumour Biol; 2017 May; 39(5):1010428317698377. PubMed ID: 28459210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma.
    Wang H; Luo F; Zhu Z; Xu Z; Huang X; Ma R; He H; Zhu Y; Shao K; Zhao J
    BMC Cancer; 2017 Mar; 17(1):222. PubMed ID: 28347288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of a gene signature in clear cell renal cell carcinoma.
    Chen L; Luo Y; Wang G; Qian K; Qian G; Wu CL; Dan HC; Wang X; Xiao Y
    J Cell Physiol; 2019 Jul; 234(7):10324-10335. PubMed ID: 30417359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and significance of Cystatin-C in clear cell renal cell carcinoma.
    Guo K; Chen Q; He X; Yao K; Li Z; Liu Z; Chen J; Liu Z; Guo C; Lu J; Wu C; Li W; Wang Q; Chen P; Lu W; Wang Y; Han H; Cao Y; Guo S
    Biomed Pharmacother; 2018 Nov; 107():1237-1245. PubMed ID: 30257338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.